ECHO THERAPEUTICS Z Score

ECTE -  USA Stock  

USD 0.0002  0.00  0.00%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Continue to Investing Opportunities.

ECHO THERAPEUTICS Z Score 

 
Refresh
ECHO THERAPEUTICS Return on Invested Capital is projected to increase significantly based on the last few years of reporting. The past year's Return on Invested Capital was at 8.05. The current year Market Capitalization is expected to grow to about 14.6 M, whereas Invested Capital Average is forecasted to decline to (2.9 M). ECHO THERAPEUTICS Interest Expense is projected to decrease significantly based on the last few years of reporting. The past year's Interest Expense was at 17,644.45. The current year Preferred Dividends Income Statement Impact is expected to grow to about 323.3 K, whereas Earning Before Interest and Taxes EBIT is forecasted to decline to (21.5 M).

ECHO THERAPEUTICS Z Score Analysis

ECHO THERAPEUTICS's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2014 2021 2022 (projected)
Interest Expense1.18 K17.64 K18.11 K
Gross Profit57.32 K51.59 K52.95 K
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )

ECHO THERAPEUTICS Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for ECHO THERAPEUTICS is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since ECHO THERAPEUTICS's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ECHO THERAPEUTICS's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ECHO THERAPEUTICS's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

According to the company's disclosures, ECHO THERAPEUTICS INC has a Z Score of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The z score for all United States stocks is 100.0% higher than that of the company.

ECHO THERAPEUTICS Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ECHO THERAPEUTICS's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ECHO THERAPEUTICS could also be used in its relative valuation, which is a method of valuing ECHO THERAPEUTICS by comparing valuation metrics of similar companies.
ECHO THERAPEUTICS is currently under evaluation in z score category among related companies.

ECHO THERAPEUTICS Fundamentals

About ECHO THERAPEUTICS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ECHO THERAPEUTICS INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ECHO THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ECHO THERAPEUTICS INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. The company was founded in 1989 and is headquartered in Iselin, New Jersey. Echo Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 19 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ECHO THERAPEUTICS without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Shere Portfolio Now

   

Shere Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Pair Trading with ECHO THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ECHO THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ECHO THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

ECHO THERAPEUTICS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for ECHO THERAPEUTICS and Bio-Rad Laboratories. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Investing Opportunities. Note that the ECHO THERAPEUTICS INC information on this page should be used as a complementary analysis to other ECHO THERAPEUTICS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Tools for ECHO THERAPEUTICS Stock

When running ECHO THERAPEUTICS INC price analysis, check to measure ECHO THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECHO THERAPEUTICS is operating at the current time. Most of ECHO THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ECHO THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ECHO THERAPEUTICS's price. Additionally, you may evaluate how the addition of ECHO THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go